Studien

Aufegteilt nach Teilgebieten der Hämostase finden sie hier unsere wissenschaftlichen Publikationen der letzten Jahre.

1. Zelluläre und vaskuläre Hämostase

Immunomodulatory drugs increase endothelial tissue factor expression in vitro, 2011
Serena Valsami, Wolfram Ruf, Maria-Sybille Leikauf, Jerzy Madon, Andres Kaech, Lars M. Asmis

Rotation thromboelastometry (ROTEM) stability and reproducibility over time, 2009
Oliver Michel Theusinger, Johannes Nürnberg, Lars M. Asmis, Burkhardt Seifert, Donat Rudolph Spahn

Treatment of midgestational placental haemorrhage with recombinant factor VIIa, 2008
Alexander Krafft, Lars M. Asmis, Roland Zimmermann

Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors, 2006
Dörthe Schmidt, MD, Lars M. Asmis, MD, Bernhard Odermatt, MD, Jens Kelm, PhD,
Christian Breymann, MD, Matthias Gössi, PhD, Michele Genoni, MD,
Gregor Zund, MD, and Simon P. Hoerstrup, MD, PhD

2. Thrombozytäre Hämostase

DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. 2010
Lars Asmis, Felix C. Tanner, Isabella Sudano, Thomas F. Lüscher, Giovanni G. Camici

DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. 2009
Lars Asmis, Felix C. Tanner, Isabella Sudano, Thomas F. Lüscher, Giovanni G. Camici

Particulate matter inhalation during hay storing activity induces systemic inXammation and platelet aggregation, 2009
B. Schicker, M. Kuhn, R. Fehr, L. M. Asmis, C. Karagiannidis, W. H. Reinhart

Heparin-induced antibodies and cardiovascular risk in patients on dialysis, 2008
Lars M. Asmis, Jodi B. Segal, Laura C. Plantinga, Nancy E. Fink, Jonathan S. Kerman, Thomas S. Kickler, Josef Coresh, Lawrence B. Gardner

In vitro norepinephrine significantly activates isolated platelets from healthy volunteers and critically ill patients following severe traumatic brain injury, 2008
Christoph Tschuor, Lars M Asmis, Philipp M Lenzlinger, Martina Tanner, Luc Härter, Marius Keel, Reto Stocker and John F Stover

Distribution and dynamic changes of sphingolipids in blood in response to platelet activation, 2006
F . Dahm, A. Nocito, A. Bielawaska, K. S. Lang, P . Georgiev, L . M. Asmis, J . Bielawski, J . Madon, Y. A. Hannun and P.-A. Clavien

3. Plasmatische Hämostase

In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM®), 2010
Oliver M. Theusinger, Werner Baulig, Lars M. Asmis, Burkhardt Seifert, Donat R. Spahn

Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART): multisite comparison of different clinical decision support systems, 2010
M. R. Nendaz, P. Chopard, C. Lovis, N. Kucher, L . M. Asmis, J . Dörffler, D. Spirk and H. Bounameaux

Kinetics of D-dimer after general surgery, 2009
Daniel Dindo, Stefan Breitenstein, Dieter Hahnloser, Burkhardt Seifert, Sidika Yakarisik, Lars M. Asmis, Markus K. Muller and Pierre-Alain Clavien

Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland, 2008
Silvia Ulrich, Brigitte Brand, Rudolf Speich, Johannes Oldenburg, Lars Asmis

Contact system activation in human sepsis – 47kD HK, a marker of sepsis severity? 2008
Lars M. Asmis, Reto Asmis, Irmela Sulzer, Miha Furlan, Bernhard Lämmle

Impact of the C2/C6 Ratio of High-molecular-weight Hydroxyethyl Starch on Pharmacokinetics and Blood Coagulation in Pigs, 2007
Sebastian Schramm, M.D., Caroline Thyes, M.D., Philippe Frascarolo, Ph.D., Thierry Buclin, M.D., Marco Burki, Andreas Fisch, Ph.D., Marc-Alexander Burmeister, M.D., Lars Asmis, M.D., Donat R. Spahn, M.D., F.R.C.A.

Effect of High- and Low-molecular-weight Low-substituted Hydroxyethyl Starch on Blood Coagulation during Acute Normovolemic Hemodilution in Pigs, 2006
Caroline Thyes, M.D., Caveh Madjdpour, M.D., Philippe Frascarolo, Ph.D., Thierry Buclin, M.D., Marco Bürki, Andreas Fisch, Ph.D., Marc-Alexander Burmeister, M.D., Lars Asmis, M.D., Donat R. Spahn, M.D., F.R.C.A.

Prekallikrein deficiency: The characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII, 2002
Lars M. Asmis, Irmela Sulzer, Miha Furlan, Bernhard Lãmmle

4. Übersichtsarbeiten & Varia

Two different hematocrit detection methods: Different methods, different results?, 2010
Marco Bosshart, John F Stover, Reto Stocker, Lars M Asmis, Jörg Feige, Thomas A Neff,
Reto A Schuepbach, Silvia R Cottini, Markus Béchir

Excessive Perioperative Bleeding, 2009
Donat R. Spahn, M.D., F.R.C.A., Lars M. Asmis, M.D.

Management venöser Thromboembolien, 2009
Dr.med. Harald Seeger, Dr.med. Lars Asmis, Dr.med.Marc Husmann

Hypercoagulability in the perioperative period, 2009
Vance G. Nielsen, MD, Lars M. Asmis, MD

Wirkungsweise alter und neuer Antikoagulanzien, 2008
Simon F. Stämpfli, Lars M. Asmis, Felix C. Tanner

Eine effektive Therapie bei sorgfältiger Indikationsstellung, 2007
Lars M. Asmis

Adriamycin promotes macrophage dysfunction in mice, 2006
Reto Asmis, Mu Qiao, Randall R. Rossi, Jill Cholewa, Li Xu, Lars M. Asmis

Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: Role of glutathione reductase and glutaredoxin, 2006
Yanmei Wang, Mu Qiao, John J. Mieyal, Lars M. Asmis, Reto Asmis

Heparin-induzierte Thrombopenie (HIT), 2004
Lars M. Asmis, Jürg Bösiger, Jörg Fehr

Acquired and Reversible Pelger-Huët Anomaly of Polymorphonuclear Neu
trophils in Three Transplant Patients Receiving Mycophenolate Mofetil Therapy, 2003

Lars M. Asmis, Karine Hadaya, Pietro Majno, Christian Toso, Frédéric Triponez, and
Michel Starobinski

Systemic Mast-Cell Disease (Mastocytosis), 2002
Lars, M. Asmis, M.D., Christophe Girardet, M.D.

Gezielter Angriff auf die einzelnen Faktoren bringt Vorteile, 2010

Grapefruit und Antibabypille vertragen sich nicht, 2009

Die Kommentarfunktion ist geschlossen.